JP2018537535A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537535A5
JP2018537535A5 JP2018549403A JP2018549403A JP2018537535A5 JP 2018537535 A5 JP2018537535 A5 JP 2018537535A5 JP 2018549403 A JP2018549403 A JP 2018549403A JP 2018549403 A JP2018549403 A JP 2018549403A JP 2018537535 A5 JP2018537535 A5 JP 2018537535A5
Authority
JP
Japan
Prior art keywords
compound according
ring
optionally substituted
fluorine
aliphatic group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549403A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018537535A (ja
JP6810156B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/065865 external-priority patent/WO2017100601A1/en
Publication of JP2018537535A publication Critical patent/JP2018537535A/ja
Publication of JP2018537535A5 publication Critical patent/JP2018537535A5/ja
Application granted granted Critical
Publication of JP6810156B2 publication Critical patent/JP6810156B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549403A 2015-12-09 2016-12-09 Pad4のアザベンゾイミダゾール阻害剤 Active JP6810156B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562264919P 2015-12-09 2015-12-09
US62/264,919 2015-12-09
PCT/US2016/065865 WO2017100601A1 (en) 2015-12-09 2016-12-09 Aza-benzimidazole inhibitors of pad4

Publications (3)

Publication Number Publication Date
JP2018537535A JP2018537535A (ja) 2018-12-20
JP2018537535A5 true JP2018537535A5 (OSRAM) 2020-01-23
JP6810156B2 JP6810156B2 (ja) 2021-01-06

Family

ID=59013635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549403A Active JP6810156B2 (ja) 2015-12-09 2016-12-09 Pad4のアザベンゾイミダゾール阻害剤

Country Status (17)

Country Link
US (1) US9765093B2 (OSRAM)
EP (1) EP3386505B1 (OSRAM)
JP (1) JP6810156B2 (OSRAM)
KR (1) KR102683681B1 (OSRAM)
CN (1) CN108601770B (OSRAM)
AR (1) AR107030A1 (OSRAM)
AU (1) AU2016366405A1 (OSRAM)
BR (1) BR112018011633A2 (OSRAM)
CA (1) CA3007954A1 (OSRAM)
EA (1) EA201891347A1 (OSRAM)
ES (1) ES2830353T3 (OSRAM)
IL (1) IL259796A (OSRAM)
MX (1) MX2018006700A (OSRAM)
SG (1) SG11201804671SA (OSRAM)
TW (1) TW201726689A (OSRAM)
UY (1) UY37017A (OSRAM)
WO (1) WO2017100601A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6926126B2 (ja) 2016-02-23 2021-08-25 パドロック・セラピューティクス・インコーポレイテッドPadlock Therapeutics, Inc. Pad4のヘテロアリール阻害剤
CN109790162B (zh) 2016-07-27 2022-06-28 帕德罗科治疗公司 Pad4的共价抑制剂
EP3510025B1 (en) 2016-09-12 2022-06-29 Padlock Therapeutics, Inc. Heteroaryl inhibitors of pad4
WO2020033490A1 (en) 2018-08-08 2020-02-13 Bristol-Myers Squibb Company Substituted thienopyrroles as pad4 inhibitors
AU2019318415A1 (en) * 2018-08-08 2021-03-25 Bristol-Myers Squibb Company Substituted benzimidazoles as PAD4 inhibitors
JP7434281B2 (ja) * 2018-08-08 2024-02-20 ブリストル-マイヤーズ スクイブ カンパニー Pad酵素のベンズイミダゾール阻害剤
MX2021001565A (es) 2018-08-08 2021-04-19 Bristol Myers Squibb Co Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
EP4100405A1 (en) 2020-02-06 2022-12-14 Bristol-Myers Squibb Company Macrocyclic pad4 inhibitors useful as immunosuppressant
TW202140477A (zh) * 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
PE20230488A1 (es) 2020-04-30 2023-03-21 Gilead Sciences Inc Inhibidores macrociclicos de las peptidilarginina deiminasas
US12240862B2 (en) 2020-12-22 2025-03-04 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
EP4267562A1 (en) 2020-12-22 2023-11-01 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
WO2025024265A1 (en) 2023-07-21 2025-01-30 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad4 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
FR2826653B1 (fr) 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1441725A1 (en) * 2001-10-26 2004-08-04 Aventis Pharmaceuticals Inc. Benzimidazoles and analogues and their use as protein kinases inhibitors
FR2862971B1 (fr) * 2003-11-28 2006-03-24 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
US8470819B2 (en) * 2008-11-03 2013-06-25 Merck Sharp & Dohme Corp. Benzimidazole and aza-benzimidazole carboxamides
SI2877467T1 (sl) * 2012-07-26 2017-02-28 Glaxo Group Limited 2-(azaindol-2-il)benzimidazoli kot PAD4 inhibitorji

Similar Documents

Publication Publication Date Title
JP2018537535A5 (OSRAM)
JP2018021051A5 (OSRAM)
JP2019537570A5 (OSRAM)
JP2013542261A5 (OSRAM)
JP2016534063A5 (OSRAM)
JP2019509276A5 (OSRAM)
JP2019516739A5 (OSRAM)
JP2014508752A5 (OSRAM)
JP2012524056A5 (OSRAM)
JP2016518437A5 (OSRAM)
JP2014511892A5 (OSRAM)
JP2012513416A5 (OSRAM)
JP2017509689A5 (OSRAM)
JP2017504635A5 (OSRAM)
JP2017528503A5 (OSRAM)
JP2013510123A5 (OSRAM)
JP2016503797A5 (OSRAM)
JP2014506907A5 (OSRAM)
JP2016527217A5 (OSRAM)
JP2017517538A5 (OSRAM)
JP2015500223A5 (OSRAM)
JP2020507589A5 (OSRAM)
JP2015508092A5 (OSRAM)
JP2019535723A5 (OSRAM)
JP2019505529A5 (OSRAM)